Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target

BACKGROUND: Glioma is a primary malignancy of the central nervous system (CNS). As biomedicine advances, an efficient molecular target is urgently needed for the diagnosis and treatment of glioma. Meanwhile, several studies have demonstrated that glioma development is closely related to immunity. PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hao, Chai, Songshan, Wang, Yihao, Wang, Jiajing, Xiao, Dongdong, Li, Junjun, Xiong, Nanxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366751/
https://www.ncbi.nlm.nih.gov/pubmed/32678519
http://dx.doi.org/10.1111/cns.13380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366751/
https://www.ncbi.nlm.nih.gov/pubmed/32678519
http://dx.doi.org/10.1111/cns.13380

Ejemplares similares